Correction: Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis

Correction: Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis

Saved in:

Bibliographic Details
Main Authors:	Daiki Tokuyasu, Shungo Imai, Shih-Pin Chen, Keiko Ihara, Narumi Watanabe, Yoshikane Izawa, Jin Nakahara, Satoko Hori, Tsubasa Takizawa
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	BMC Neurology
Online Access:	https://doi.org/10.1186/s12883-025-04052-4
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of lacosamide on cortical spreading depolarization in mice
by: Chisato Iba, et al.
Published: (2025-07-01)

New specific migraine prevention: monoclonal antibodies against calcitonin gene-related peptide and its receptor
by: K. Ryliškienė, et al.
Published: (2019-12-01)

Anti-Calcitonin Gene-Related Peptide Monoclonal Antibody Is Effective for Preventing Migraine Aura Without Headache
by: Yasushi Shibata
Published: (2024-10-01)

Efficacy of anti-calcitonin gene-related peptide monoclonal antibodies in hemiplegic migraine: a case report and review of literature
by: Máté Héja, et al.
Published: (2025-04-01)

Efficacy of Monoclonal Antibodies Against Calcitonin Gene-Related Peptide for Medication Overuse Headache in Migraine Patients: Literature Review
by: A. Kairytė, et al.
Published: (2024-12-01)

A National Cross-Sectional Survey on Real-World Experiences of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody Use in Adults with Migraine in Finland
by: Caroline S. Casey, et al.
Published: (2025-04-01)

Cortical Thickness Changes in Migraine Patients Treated with Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies: A Prospective Age- and Sex-Matched Controlled Study
by: Soohyun Cho
Published: (2025-05-01)

Croatian guidelines for specific preventive treatment of migraine with monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) (eptinezumab, fremanezumab, and galcanezumab) or the CGRP receptor (erenumab)
by: Davor Jančuljak, et al.
Published: (2024-01-01)

Identifying the Relative Importance of Factors Influencing Medication Compliance in General Patients Using Regularized Logistic Regression and LightGBM: Web-Based Survey Analysis
by: Haru Iino, et al.
Published: (2024-12-01)

Construction of Personalized Predictive Models for Missed Medication Doses Using Wearable Device Data: Prospective Observational Study
by: Haru Iino, et al.
Published: (2025-06-01)

The Effect of Calcitonin Gene-Related Peptide Monoclonal Antibodies on Quality of Life among Migraine Patients: Pilot Study at the Hospital of Lithuanian University of Health Sciences Kaunas Clinics
by: Monika Remenčiūtė, et al.
Published: (2024-05-01)

Calcitonin gene-related peptide monoclonal antibody treatment for new daily persistent headache
by: Sanjay Cheema, et al.
Published: (2025-07-01)

Plasma level of calcitonin gene-related peptide in the diagnosis of episodic migraine with comorbid conditions
by: O. Ye. Dubenko, et al.
Published: (2022-12-01)

Incidence Status and Factors Associated With Tyrosine Kinase Inhibitor‐Induced Hypertension in Patients With Renal Cell Carcinoma
by: Satoru Nakanishi, et al.
Published: (2025-05-01)

Clinical practice for migraine treatment and characteristics of medical facilities and physicians treating migraine: Insights from a retrospective cohort study using a Japanese claims database.
by: Tsubasa Takizawa, et al.
Published: (2024-01-01)

Calcitonin gene-related peptide-targeting drugs efficiently treat abdominal migraine—A case report
by: Thisayini Baskaran, et al.
Published: (2025-05-01)

Caveolin-1 negatively regulates the calcitonin receptor-like receptor and neuroinflammation in a female mouse model of migraine
by: Yanjie Zhou, et al.
Published: (2025-05-01)

Calcitonin gene-related peptide monoclonal antibodies and medication-overuse headache: stopping excessive pain medication is still necessary
by: Pedro Augusto Sampaio Rocha-Filho
Published: (2025-09-01)

Calcitonin gene-related peptide monoclonal antibodies and medication overuse headache: is stopping excessive pain medication still necessary?
by: João José Freitas de Carvalho
Published: (2025-09-01)

Population pharmacokinetic modeling of zavegepant, a calcitonin gene‐related peptide receptor antagonist, in healthy adults and patients with migraine
by: Craig M. Comisar, et al.
Published: (2025-01-01)

In the era of monoclonal antibodies targeting the calcitonin gene-related peptide pathway, is it still necessary to stop taking excessive pain medication?
by: Renata Gomes Londero
Published: (2025-09-01)

Sex differences in the effects of calcitonin gene-related peptide signaling on migraine-like behavior in animal models: a narrative review
by: Lakeisha A. Lewter, et al.
Published: (2025-07-01)

Unveiling the efficacy and safety of Erenumab, a monoclonal antibody targeting calcitonin gene-related peptide (CGRP) receptor, in patients with chronic and episodic migraine: a GRADE-assessed systematic review and meta-analysis of randomized clinical trials with subgroup analysis
by: Mohamed E. Haseeb, et al.
Published: (2025-03-01)

Interictal burden in migraine patients at the outset of CGRP monoclonal antibody prevention
by: Christian Lampl, et al.
Published: (2024-12-01)

Utility analysis and demonstration of real-world clinical texts: A case study on Japanese cancer-related EHRs.
by: Shuntaro Yada, et al.
Published: (2024-01-01)

Correction: Utility analysis and demonstration of real-world clinical texts: A case study on Japanese cancer-related EHRs.
by: Shuntaro Yada, et al.
Published: (2025-01-01)

Estimation of calcitonin and calcitonin gene-related peptide-α in bone calcification in quail during laying period
by: Hadeel M. Hameed, et al.
Published: (2025-01-01)

The dual impact of ictal and interictal burden in migraine: an analysis from the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME) Japan second study
by: Tsubasa Takizawa, et al.
Published: (2025-06-01)

It is time anti-CGRP monoclonal antibodies be considered first-line prophylaxis for migraine
by: Gabriel Taricani Kubota
Published: (2022-08-01)

Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
by: Caio Vinicius de Meira Grava Simioni
Published: (2022-08-01)

The Impact of Migraine on the Whole Life Course of Patients: Results from the OVERCOME (Japan) 2nd Study
by: Daisuke Danno, et al.
Published: (2024-12-01)

Improving Systematic Review Updates With Natural Language Processing Through Abstract Component Classification and Selection: Algorithm Development and Validation
by: Tatsuki Hasegawa, et al.
Published: (2025-03-01)

Patient Preferences for Episodic Migraine Medications: A Discrete Choice Experiment of Self-Injectable Versus Oral Treatments Targeting Calcitonin Gene-Related Peptide Pathway
by: Whichello C, et al.
Published: (2025-03-01)

Preclinical characterization of an active immunotherapy targeting calcitonin gene-related peptide
by: Justin D. Boyd, et al.
Published: (2025-04-01)

Differentially localizing isoforms of the migraine component calcitonin gene-related peptide (CGRP), in the mouse trigeminal ganglion: βCGRP is translated but, unlike αCGRP, not sorted into axons
by: Sofia Lyng Wæver, et al.
Published: (2025-01-01)

Chilblains with CGRP monoclonal antibody treatment of chronic migraine: A case report and literature review
by: Bradley Torphy, et al.
Published: (2025-03-01)

Overview of Calcitonin Gene-Related Peptide and Its Receptor
by: Nambi Aiyar
Published: (2001-01-01)

Calcitonin-Secreting Neuroendocrine Carcinoma of Larynx with Metastasis to Thyroid
by: Lauren LaBryer, et al.
Published: (2015-01-01)

Real-world use of over-the-counter medications by patients with migraine in Japan: results from the OVERCOME (Japan) 2nd study
by: Ryotaro Ishii, et al.
Published: (2025-05-01)

Disrupting Migraine Dynamics: A Narrative Review of the Consequences of Modern Anti-CGRP Monoclonal Antibody Therapies
by: Dawn C. Buse, et al.
Published: (2025-05-01)